Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Yu Li, Cangang Zhang, Aimin Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Shengkun Peng, Anqi Lin, Aimin Jiang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Gamma/delta T cells as cellular vehicles for anti-tumor immunity
Chelsia Qiuxia Wang, Pei Yu Lim, Andy Hee‐Meng Tan
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
Novel potential therapeutic targets of alopecia areata
Wen Xu, Sheng Wan, Bo Xie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
T cells in abdominal aortic aneurysm: immunomodulation and clinical application
Wei Gong, Yu Tian, Lei Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 6
T cell exhaustion in human cancers
Kuan Kang, Xin Lin, Pan Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189162-189162
Closed Access | Times Cited: 6
Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer
Qing Hao, Ruicen Li, Hancong Li, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 5
Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes
Chunyu Zhang, Xing Zhang, Shengjie Dai, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Decoding the mechanisms behind second primary cancers
Meiyuan Zeng, Anqi Lin, Aimin Jiang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Artificial intelligence-based radiogenomics reveals the potential immunoregulatory role of COL22A1 in glioma and its induced autoimmune encephalitis
Bingchao Yan, Qian Chen, Da‐Cheng Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia
Michał Zarobkiewicz, Natalia Lehman, Izabela Morawska, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 451-451
Open Access
Diverse Subsets of γδT Cells and Their Specific Functions Across Liver Diseases
Chenjie Zhan, Chunxiu Peng, Hui Wei, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2778-2778
Open Access
Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance
Lanyue Zhang, Jiangnan Zhao, Changqing Su, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
γδ T cells and head and neck squamous cell carcinoma
Jiayu Peng, Huibin Qiu, Lin‐Lin Bu, et al.
International review of cell and molecular biology (2025)
Closed Access
Gamma delta T cells and their immunotherapeutic potential in cancer
Stephen G. Cieslak, Reza Shahbazi
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Management of metastatic melanoma with combinations including PD-1 inhibitors
Lara Valeska Maul, Egle Ramelyte, Reinhard Dummer, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access
Heterogeneity of γδ T-cell subsets and their clinical correlation in patients with AML
Siyuan Jiang, Shiyu Zheng, Chao Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system
Ri Hong, Puguang Yu, Xiaoli Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics
Sylwia Biały, Katarzyna Bogunia‐Kubik
Frontiers in Immunology (2025) Vol. 16
Open Access
Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker
Ruicheng Wu, Dengxiong Li, Shuxia Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Suppressor effects of carrots on azoxymethane/dextran sulfate sodium-induced colon cancer according to cultivation method
Yanni Pan, Yeon-Jun Lee, Jae Hyoung Kim, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy
Isabella A. Revesz, Paul Joyce, Lisa M. Ebert, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 4
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives
Zhiyi Ye, Pu Cheng, Qi Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top